Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 31 AL 45

Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer's disease

Harrison JE.

Alzheimers Res Ther. 2018 Jun 29;10(1):61. doi: 10.1186/s13195-018-0386-7.

Editorial: Plasma Biomarker for Alzheimer's Disease: Are We Ready Now for Clinical Practice and Drug Trials?

Nakamura A.

J Prev Alzheimers Dis. 2018;5(3):158-159. doi: 10.14283/jpad.2018.24.

The TRPM2 channel nexus from oxidative damage to Alzheimer's pathologies: An emerging novel intervention target for age-related dementia

Jiang LH, Li X, Syed Mortadza SA, Lovatt M, Yang W.

Ageing Res Rev. 2018 Nov;47:67-79. doi: 10.1016/j.arr.2018.07.002. Epub 2018 Jul 17.

Calcium signaling in Alzheimer's disease & therapies

Tong BC, Wu AJ, Li M, Cheung KH.

Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1745-1760. doi: 10.1016/j.bbamcr.2018.07.018. Epub 2018 Jul 29.

Derivation of induced pluripotent stem cells TUSMi006 from an 87-year old Chinese Han Alzheimer's disease patient carrying GRINB and SORL1 mutations

Wang Y, Yu H, Chen Y, Li G, Lei Y, Zhao J.

Stem Cell Res. 2018 Aug;31:127-130. doi: 10.1016/j.scr.2018.07.018. Epub 2018 Jul 25.

Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

Kolaj I, Imindu Liyanage S, Weaver DF.

Neurochem Int. 2018 Nov;120:99-111. doi: 10.1016/j.neuint.2018.08.001. Epub 2018 Aug 8.

Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?

Dunys J, Valverde A, Checler F.

J Biol Chem. 2018 Oct 5;293(40):15419-15428. doi: 10.1074/jbc.R118.003999. Epub 2018 Aug 24.

Erythropoietin preparation drastically improved activities of daily living in a patient with severe dementia

Kumagai R, Koike M, Iwase Y, Ichimiya Y.

Psychiatry Clin Neurosci. 2018 Nov;72(11):849. doi: 10.1111/pcn.12777. Epub 2018 Oct 8.

Potential roles of brain barrier dysfunctions in the early stage of Alzheimer's disease

Jian WX, Zhang Z, Chu SF, Peng Y, Chen NH.

Brain Res Bull. 2018 Sep;142:360-367. doi: 10.1016/j.brainresbull.2018.08.012. Epub 2018 Aug 25.

Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease

Lei Y, Renyuan Z.

Endocrinology. 2018 Dec 1;159(12):3885-3894. doi: 10.1210/en.2018-00660.

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Ide K, Matsuoka N, Yamada H, Furushima D, Kawakami K.

Molecules. 2018 Sep 14;23(9):2357. doi: 10.3390/molecules23092357.

Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

Doig AJ.

J Alzheimers Dis. 2018;66(1):25-36. doi: 10.3233/JAD-180583.

The Implications of Autophagy in Alzheimer's Disease

Hamano T, Hayashi K, Shirafuji N, Nakamoto Y.

Curr Alzheimer Res. 2018;15(14):1283-1296. doi: 10.2174/1567205015666181004143432.

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

Ramos de Matos M, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperi HBJ, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, Resende de Oliveira C, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M.

J Alzheimers Dis. 2018;66(2):639-652. doi: 10.3233/JAD-180512.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias